日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TM6SF2 and PNPLA3: A potential dynamic duo?: Editorial on "TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD"

TM6SF2 和 PNPLA3:潜在的动态组合?:关于“TM6SF2 E167K 变体降低 PNPLA3 介导的 PUFA 转移,从而促进 MASLD 中的肝脂肪变性和损伤”的社论

Caddeo, Andrea; Mancina, Rosellina M

Precision medicine and nucleotide-based therapeutics to treat steatotic liver disease

精准医疗和基于核苷酸的疗法用于治疗脂肪肝疾病

Caddeo, Andrea; Romeo, Stefano

Galectin-3 inhibition ameliorates hepatic steatosis in a multilineage 3D spheroid model.

Galectin-3 抑制剂可改善多系 3D 球状体模型中的肝脂肪变性

Sedda Francesca, Caddeo Andrea, Sasidharan Kavitha, Perra Giovanni, Pal Rajesh, Lai Nicola, Kowalik Marta Anna, Perra Andrea

Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease

非酒精性脂肪性肝病患者的端粒酶逆转录酶种系突变与肝细胞癌

Donati, Benedetta; Pietrelli, Alessandro; Pingitore, Piero; Dongiovanni, Paola; Caddeo, Andrea; Walker, Lucy; Baselli, Guido; Pelusi, Serena; Rosso, Chiara; Vanni, Ester; Daly, Ann; Mancina, Rosellina Margherita; Grieco, Antonio; Miele, Luca; Grimaudo, Stefania; Craxi, Antonio; Petta, Salvatore; De Luca, Laura; Maier, Silvia; Soardo, Giorgio; Bugianesi, Elisabetta; Colli, Fabio; Romagnoli, Renato; Anstee, Quentin M; Reeves, Helen L; Fracanzani, Anna Ludovica; Fargion, Silvia; Romeo, Stefano; Valenti, Luca